Ss Innovations International Inc. (SSII)
NASDAQ (CM) NASDAQ (CM) Primary 
SS Innovations to Uplist to Nasdaq
Listened: Fort Lauderdale, FL, April 24, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations to Uplist to Nasdaq
FORT LAUDERDALE, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”).
SS Innovations Achieves Significant Milestones in 2024
FORT LAUDERDALE, FL, March 31, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
Fort Lauderdale, Fla. March 28, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India's first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures.
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
Fort Lauderdale, FL, March 27, 2025 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative robotic surgical technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it successfully performed India's first North-to-South robotic cardiac telesurgery.
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
Fort Lauderdale, Fla., January 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
FORT LAUDERDALE, Fla., Dec. 11, 2024 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its new independent registered public accounting firm, BDO India LLP (“BDO”), has completed the re-audit of the Company's consolidated financial statements for the years ended December 31, 2023 and December 31, 2022, which were included in the Company's previously filed Annual Report on Form 10-K for the year ended December 31, 2023 (the “Original Filing”).
India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
FORT LAUDERDALE, Fla., Dec. 10, 2024 – PRISM MediaWire – SS Innovations International, Inc.
India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics SS Innovations reinforces India's position as a hub for technological innovation in healthcare using the SSi Mantra - Made in India, for the World The SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and control for improved patient outcome FORT LAUDERDALE, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has achieved a milestone in Indian medical science by becoming the first and only company in India to receive Central Drugs Standard Control Organization (CDSCO) regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, signifying a significant achievement in surgical robotics.
